首页> 外文期刊>European journal of medical research. >Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
【24h】

Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.

机译:重度原发性高血压患者舌下维拉帕米的疗效:与舌下硝苯地平比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Ninety patients, 50 males and 40 females, and their ages ranged between 42 and 70 years, with severe hypertension were treated by either sublingual verapamil tablets 40 mg (30 patients) or 80 mg (30 patients) or sublingual nifedipine capsules 10 mg (30 patients). Blood pressure and heart rate were measured before and 15, 30, 60, 90 and 120 mins after administration of the drugs. - Results showed that sublingual verapamil 40 mg caused significant drop of blood pressure after 60 min (200 +/- 11.6 / 127 +/- 8.7 to 177 +/- 13.8 / 95.4 +/- 11.8, P <0.05) and in 10/30 patients blood pressure was less than 150/90 mmHg. Verapamil 40 mg decreased heart rate in 16 patients, elevated in 5 patients and unchanged heart rate in 9 patients. Verapamil 80 mg caused significant reduction of blood pressure after 30 min (201 +/- 16 / 129 +/- 7.5 to 182 +/- 13 / 105 +/- 10.7, P <0.05) and the blood pressure was dropped to less than 150/90 mmHg in 18/30 patients. Sublingual verapamil 80 mg caused significant decrease in heart rate in 21/30 patients and peak decrease was recorded at 90 min (92.6 +/- 7.2 beats/min to 82 +/- 9, P <0.05). It alleviated headache in 8 patients including 2 patients with migraine. Sublingual nifedipine caused significant drop of elevated blood pressure at each time intervals and the peak drop was at 60 min (from 199 +/- 13.8 / 126 +/- 13.2 to 142.8 +/- 15 / 80. 9 +/- 9, P <0.05). In 22/30 patients blood pressure dropped to less than 150/90 mmHg after 60 min. Nifedipine elevated heart rate in 22/30 patients and peak elevation was at 30 min (from 91.6 +/- 7.8 to 105.6 +/- 6.1 beats/min, P <0.05). It caused headache in 8 patients and flushing in other 2 patients. Therefore, as compared to sublingual verapamil, sublingual nifedipine caused rapid lowering of elevated blood pressure and elevation of heart rate in most of the patients treated. The differences in proportions of patients whom blood pressure was dropped to less than 150/90 mmHg between nifedipine group and verapamil 40 mg group and between verapamil 80 mg and verapamil 40 mg groups were significant (P <0.05). - It might be concluded that sublingual verapamil caused significant lowering of blood pressure in hypertensive patients, decreased heart rate in most of the treated patients and alleviated headache in symptomatic hypertensive patients.
机译:患有重度高血压的90例患者,男50例,女40例,年龄在42至70岁之间。他们接受舌下维拉帕米片40 mg(30例)或80 mg(30例)或舌下硝苯地平胶囊10 mg(30例)治疗耐心)。在给药前和给药后15、30、60、90和120分钟测量血压和心率。 -结果显示,舌下维拉帕米40 mg在60分钟后引起血压显着下降(200 +/- 11.6 / 127 +/- 8.7至177 +/- 13.8 / 95.4 +/- 11.8,P <0.05)和10 / 30名患者的血压低于150/90 mmHg。维拉帕米40 mg可使16例患者的心率降低,5例患者的心率升高以及9例患者的心率保持不变。维拉帕米80 mg在30分钟后引起血压显着降低(201 +/- 16/129 +/- 7.5至182 +/- 13/105 +/- 10.7,P <0.05)并且血压降至低于150/90 mmHg在18/30患者中。舌下维拉帕米80 mg引起21/30患者的心率显着下降,并在90分钟时出现峰值下降(92.6 +/- 7.2次/分,达到82 +/- 9,P <0.05)。它减轻了8例患者的头痛,其中包括2例偏头痛。舌下硝苯地平在每个时间间隔都会导致血压显着下降,峰值下降在60分钟时(从199 +/- 13.8 / 126 +/- 13.2到142.8 +/- 15 /80。9 +/- 9,P <0.05)。在22/30患者中,血压在60分钟后降至低于150/90 mmHg。硝苯地平升高的心率在22/30患者中,峰值升高出现在30分钟时(从91.6 +/- 7.8到105.6 +/- 6.1次/分钟,P <0.05)。它导致8例头痛,另2例引起潮红。因此,与舌下维拉帕米相比,舌下硝苯地平在大多数接受治疗的患者中引起血压升高和心率升高的迅速降低。硝苯地平组和维拉帕米40 mg组之间以及维拉帕米80 mg和维拉帕米40 mg组之间血压降至150/90 mmHg以下的患者比例差异显着(P <0.05)。 -可以得出结论,舌下维拉帕米可引起高血压患者的血压显着降低,大多数接受治疗的患者的心率降低以及症状性高血压患者的头痛减轻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号